Form 4 for AXSM Axsome Therapeutics, Inc.
Accepted 2026-01-07 00:00:00 ET · period of report 2026-01-05 · accession 0001193125-26-006695 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-01-07 | 2026-01-05+ | AXSM | TABUTEAU HERRIOT | CEO, Dir, 10% | M - OptEx | $8.02 | +139.4K | 36.7K | New | +$1.12M |
| DMT | 2026-01-07 | 2026-01-05+ | AXSM | TABUTEAU HERRIOT | CEO, Dir, 10% | S - Sale+OE | $171.30 | -139.4K | 7,229 | -95% | -$23.88M |
| DMT | 2026-01-07 | 2026-01-05+ | AXSM | TABUTEAU HERRIOT | CEO, Dir, 10% | M - OptEx | $0.00 | -139.4K | 93.1K | -60% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-05 | M | A | 78,703 | $8.02 | 85,932 | D | — | — | |
| 2 | Common | Common Stock | 2026-01-05 | S | D | 78,703 | $171.28 | 7,229 | D | — | — | (F4) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $168.58 and $178.60. |
| 3 | Common | Common Stock | 2026-01-07 | S | D | 31,261 | $170.38 | 7,229 | D | — | — | (F6) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $168.15 and $173.17. |
| 4 | Common | Common Stock | 2026-01-06 | S | D | 29,450 | $172.33 | 7,229 | D | — | — | (F5) Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $170.36 and $175.26. |
| 5 | Common | Common Stock | 2026-01-07 | M | A | 31,261 | $8.02 | 38,490 | D | — | — | |
| 6 | Common | Common Stock | 2026-01-06 | M | A | 29,450 | $8.02 | 36,679 | D | — | — | |
| 7 | Derivative | Stock Option (Right to Buy) | 2026-01-07 | M | D | 31,261 | $0.00 | 32,410 | D | $170.38 · 2017-05-27 to 2026-05-27 | 31,261 Common Stock | |
| 8 | Derivative | Stock Option (Right to Buy) | 2026-01-06 | M | D | 29,450 | $0.00 | 63,671 | D | $172.33 · 2017-05-27 to 2026-05-27 | 29,450 Common Stock | |
| 9 | Derivative | Stock Option (Right to Buy) | 2026-01-05 | M | D | 78,703 | $0.00 | 93,121 | D | $171.28 · 2017-05-27 to 2026-05-27 | 78,703 Common Stock |